28 results on '"Perumpail, Brandon J."'
Search Results
2. The prevalence and predictors of metabolic dysfunction‐associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults
3. Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States
4. Clinical Epidemiology of NAFLD
5. Trends in aetiology‐based hospitalisation for cirrhosis before and during the COVID ‐19 pandemic in the United States
6. Clinical Epidemiology of NAFLD
7. Changing trends in aetiology‐based hospitalizations with end‐stage liver disease in the United States from 2016 to 2019
8. Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease
9. Changing Trends in Etiology‐Based and Ethnicity‐Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States
10. Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
11. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
12. An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease
13. Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents
14. Disparate Trends in Incidence and Mortality of Metastatic Hepatocellular Carcinoma Within the Asian and Hispanic Populations
15. Malnourished HCC Patients Associated with Highest Inpatient Mortality Among GI Cancers
16. Nutritional Needs and Support for Children with Chronic Liver Disease.
17. Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis.
18. Tu1518 - Disparate Trends in Incidence and Mortality of Metastatic Hepatocellular Carcinoma Within the Asian and Hispanic Populations
19. Sa1451 - Malnourished HCC Patients Associated with Highest Inpatient Mortality Among GI Cancers
20. The importance of a multidisciplinary approach to hepatocellular carcinoma.
21. The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD.
22. Anti-Diabetic Medications for the Pharmacologic Management of NAFLD.
23. When to Initiate Weight Loss Medications in the NAFLD Population.
24. Judicious Use of Lipid Lowering Agents in the Management of NAFLD.
25. The Role of Vitamin E in the Treatment of NAFLD.
26. Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD.
27. Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD.
28. The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.